Introduction Developing a compliant Biosimilar Regulatory Dossier Structure demands an in-depth understanding of the sophisticated analytical expectations established by global […]
Biosimilar Regulatory Dossier Structure: Building the CTD Module 3 Analytical Package Read More »
Introduction: Trastuzumab biosimilar analytical characterization is the foundation on which any HER2-targeted biosimilar’s regulatory approval is built, since agencies require
Introduction The formation of an acidic microenvironment during the degradation of poly(lactic-co-glycolic acid) (PLGA) matrices represents one of the most
Introduction Implementing the ICH Q6B Guidelines for Biological Characterisation requires a comprehensive, multi-orthogonal analytical strategy to verify that a proposed
Introduction: Matrix effects in LC-MS/MS bioanalysis are among the most significant challenges affecting the reliability of pharmacokinetic, toxicokinetic, and therapeutic
Matrix Effects in LC-MS/MS Bioanalysis: Causes, Detection, and Mitigation Strategies Read More »
Introduction: Peptide therapeutics are one of the fastest-growing drug classes in the pharmaceutical pipeline, but their structural complexity demands rigorous
Introduction Obtain regulatory approval for IND, NDA, and BLA submissions with the support of professional Extractables & Leachables (E&L) Consulting
Introduction: PLGA for pulmonary drug delivery has become a focal point for formulators seeking to extend the therapeutic window of
Introduction Cell-Penetrating Peptides in Oligonucleotide Conjugates are sophisticated chimeric macromolecules developed to address the significant challenge of poor cellular uptake
Introduction Characterization Methods for PLGA Microspheres involve a comprehensive range of advanced analytical techniques used to assess the physicochemical properties,
